- Home
- EVGO vs TERN Comparison
EVGO vs TERN Comparison
Compare EVGO & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGO
- TERN
- Stock Information
- Founded
- EVGO 2010
- TERN 2017
- Country
- EVGO United States
- TERN United States
- Employees
- EVGO N/A
- TERN N/A
- Industry
- EVGO Other Specialty Stores
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- EVGO Consumer Discretionary
- TERN Health Care
- Exchange
- EVGO Nasdaq
- TERN Nasdaq
- Market Cap
- EVGO 674.8M
- TERN 710.6M
- IPO Year
- EVGO N/A
- TERN 2021
- Fundamental
- Price
- EVGO $4.11
- TERN $8.26
- Analyst Decision
- EVGO Buy
- TERN Buy
- Analyst Count
- EVGO 8
- TERN 7
- Target Price
- EVGO $5.70
- TERN $13.99
- AVG Volume (30 Days)
- EVGO 3.9M
- TERN 1.8M
- Earning Date
- EVGO 11-10-2025
- TERN 11-12-2025
- Dividend Yield
- EVGO N/A
- TERN N/A
- EPS Growth
- EVGO N/A
- TERN N/A
- EPS
- EVGO N/A
- TERN N/A
- Revenue
- EVGO $308,365,000.00
- TERN N/A
- Revenue This Year
- EVGO $45.13
- TERN N/A
- Revenue Next Year
- EVGO $26.83
- TERN N/A
- P/E Ratio
- EVGO N/A
- TERN N/A
- Revenue Growth
- EVGO 49.06
- TERN N/A
- 52 Week Low
- EVGO $2.20
- TERN $1.87
- 52 Week High
- EVGO $8.42
- TERN $9.03
- Technical
- Relative Strength Index (RSI)
- EVGO 44.48
- TERN 53.42
- Support Level
- EVGO $3.81
- TERN $7.87
- Resistance Level
- EVGO $4.29
- TERN $8.87
- Average True Range (ATR)
- EVGO 0.22
- TERN 0.67
- MACD
- EVGO -0.06
- TERN -0.05
- Stochastic Oscillator
- EVGO 30.96
- TERN 62.30
About EVGO EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.